Closure of Trading Wndow

To, Date:30-09-2026 The Listing Compliance Department, BSE Limited, P. J. Tower, Dalal Street, Mumbai - 400 020, Maharashtra, India. Scrip: 526504; DOLPHMED Subject: Intimation of Closure of Trading Window Ref: Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("SEBI PIT Regulations") Dear Sir/Ma’am This is to inform you that pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company’s Code of Conduct to Regulate, Monitor and Report Trading in Shares by Designated Persons, the trading window for trading in securities of the Company by the designated persons including Insiders, as per the Insider Trading Code, shall remain closed with effect from Thursday, October 01, 2026 till the end of 48 hours. after the announcement/declaration of Un-audited Financial Results (Standalone) of the Company for the 2" Quarter Ended September 30, 2026. The date of the Board meeting to consider the aforesaid financial results, shall be intimated separately in due course. We request to take the above information on your records and disseminate the same on your website For DOLPHIN MEDICAL SERVICES LIMITED Director M. Rajesh Kumar DIN: 08125774 DOLPHIN MEDICAL SERVICES LIMITED CIN: L24239TG1992PLC014775 Registered Office: Level 3, Plot No 13, Greenlands Colony, Besides Flyover Gachibowli, Hyderabad– 500032 Email: dolphinmedicalindia@gmail.com; Ph No : +91 7981598498